NEB Wins Co-Exclusive Rights to Sell seqWell's TnX Transposase
Image
Ipswich, Mass. – October 15, 2026 -- New England Biolabs (NEB) has secured co-exclusive rights to sell seqWell's TnX Transposase and the right to manufacture the enzyme and include it in NEB kits and products, under a strategic partnership announced alongside the commercial launch of TnX Transposase (Unloaded).
NEB gains sales and manufacturing rights under the agreement
The deal gives NEB two rights: co-exclusive sales of TnX Transposase, and manufacturing of TnX for incorporation into its own kits. seqWell keeps selling TnX-based library preparation kits through its own channel.
NEB cites more than 50 years of enzyme manufacturing and quality control as its contribution. seqWell supplies the engineered enzyme and its transposase expertise.